Canaccord Genuity Group Lowers Bioceres Crop Solutions (NASDAQ:BIOX) Price Target to $7.00

Bioceres Crop Solutions (NASDAQ:BIOX) had its target price decreased by investment analysts at Canaccord Genuity Group from $9.50 to $7.00 in a note issued to investors on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s price target points to a potential upside of 25.56% from the stock’s previous close.

Separately, Oppenheimer dropped their target price on shares of Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating for the company in a report on Tuesday, January 28th. Four equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, Bioceres Crop Solutions currently has an average rating of “Buy” and an average price target of $11.25.

Bioceres Crop Solutions Stock Performance

NASDAQ:BIOX traded down $0.01 during mid-day trading on Friday, hitting $5.58. 621,461 shares of the company traded hands, compared to its average volume of 237,374. The stock’s fifty day moving average price is $6.65 and its 200-day moving average price is $7.86. Bioceres Crop Solutions has a one year low of $5.50 and a one year high of $14.05. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.37. The firm has a market cap of $349.61 million, a price-to-earnings ratio of 277.79 and a beta of 0.57.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its earnings results on Monday, November 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.11). The company had revenue of $92.60 million for the quarter, compared to the consensus estimate of $117.15 million. Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. During the same period last year, the business posted ($0.07) EPS. Research analysts anticipate that Bioceres Crop Solutions will post 0.12 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Bioceres Crop Solutions

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Ping Capital Management Inc. boosted its position in shares of Bioceres Crop Solutions by 7.3% in the fourth quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock valued at $268,000 after acquiring an additional 3,000 shares during the period. Stifel Financial Corp increased its holdings in Bioceres Crop Solutions by 33.4% in the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock worth $321,000 after acquiring an additional 10,224 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Bioceres Crop Solutions by 9.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after acquiring an additional 5,341 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Bioceres Crop Solutions by 49.3% during the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock valued at $708,000 after purchasing an additional 29,693 shares during the period. Finally, Fourth Sail Capital LP raised its holdings in Bioceres Crop Solutions by 16.6% in the fourth quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company’s stock worth $22,490,000 after purchasing an additional 527,859 shares in the last quarter. Institutional investors and hedge funds own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.